DICL_CP_0333894 - DICL Database

Basic Molecular Information

Basic Information

DICL ID

DICL_CP_0333894

PubChem CID

2726

Molecular Formula

C₁₇H₁₉ClN₂S

Molecular Weight

318.873 g/mol

Synonyms/Alias

[chlorpromazine; Thorazine; 50-53-3; Largactil; Chloropromazine; Aminazine; Contomin; Chlorderazin; Propaphenin; Chlorpromados; Fenactil; Sanopron; Wintermin; Esmind; Largactilothiazine; Megaphen; Nov...[chlorpromazine; Thorazine; 50-53-3; Largactil; Chloropromazine; Aminazine; Contomin; Chlorderazin; Propaphenin; Chlorpromados; Fenactil; Sanopron; Wintermin; Esmind; Largactilothiazine; Megaphen; Novomazina; Chlorpromazinum; Chlorpromazin; Largactyl; Phenactyl; Promactil; Aminazin; Elmarin; Fenaktyl; Promazil; Torazina; 2-Chloropromazine; Proma; Prozil; Chlor-Promanyl; Clorpromazina; Ampliactil; Psychozine; Fraction AB; 3-(2-chloro-10H-phenothiazin-10-yl)-N;N-dimethylpropan-1-amine; Amplictil; Aminasine; SKF 2601-A; Chlor-PZ; HL 5746; 10H-Phenothiazine-10-propanamine; 2-chloro-N;N-dimethyl-; BC 135; CPZ; Cromedazine; Plegomasine; Amplicitil; 3-(2-chlorophenothiazin-10-yl)-N;N-dimethylpropan-1-amine; N-(3-Dimethylaminopropyl)-3-chlorophenothiazine; HSDB 3033; Chlorpromazinum [INN-Latin]; Clorpromazina [INN-Spanish]; Chlorpromazine Tannate; 4560 R.P.; 3-(2-chlorophenothiazin-10-yl)-N;N-dimethyl-propan-1-amine; CCRIS 3711; CHEBI:3647; [3-(2-chloro-10H-phenothiazin-10-yl)propyl]dimethylamine; UNII-U42B7VYA4P; Hemoglobin kodaira; EINECS 200-045-8; U42B7VYA4P; 2-Cloro-10 (3-dimetilaminopropil)fenotiazina; 2-chloro-N;N-dimethyl-10H-Phenothiazine-10-propanamine; NSC 167745; NSC-167745; 3-(2-Chloro-10H-phenothiazin-10-yl)-N;N-dimethyl-1-propanamine; 34468-21-8; DTXSID0022808; 2-Chloro-10-(3-(dimethylamino)propyl)phenothiazine; 2-Chloro-10-[3-(dimethylamino)propyl]phenothiazine; Chloro-3 (dimethylamino-3 propyl)-10 phenothiazine; SKF-2601A; CHEMBL71; GG 407; NSC-226514; J2.794D; Phenothiazine; 2-chloro-10-(3-(dimethylamino)propyl)-; DTXCID002808; Chlorpromazine [USP:INN:BAN]; Phenothiazine hydrochloride; Hibanil; Unitensen; NSC167745; Phenothiazine; 2-chloro-10-[3-(dimethylamino)propyl]-; NCGC00015273-11; Thorazine Suppositories; Clorpromazina [Italian]; Chlorpromazinum (INN-Latin); Clorpromazina (INN-Spanish); 146702-01-4; CHLORPROMAZINE (MART.); CHLORPROMAZINE [MART.]; Chlorpromazine (USP:INN:BAN); Prazilpromactil; Chlordelazin; Phenathyl; chlorpromethazine; CHLORPROMAZINE (USP MONOGRAPH); CHLORPROMAZINE [USP MONOGRAPH]; CAS-50-53-3; Thorazine (TN); Z80; chlorpromazine cation; [3-(2-chloro-10H-phenothiazin-10-yl)propyl]dimethylamine hydrochloride; CAS-69-09-0; Chlorpromazine (USP/INN); Chlorpromazine cation radical; Amplicatil; Chlropromados; Fraction; 2-Cloro-10 (3-dimetilaminopropil)fenotiazina [Italian]; JHICC02042; Chloro-3 (dimethylamino-3 propyl)-10 phenothiazine [French]; SKF 2601A; SKF-2601; Hibernal (Salt/Mix); Lomazine (Salt/Mix); Tranzine (Salt/Mix); Norcozine (Salt/Mix); Spectrum_000142; Prestwick0_000064; Prestwick1_000064; Prestwick2_000064; Prestwick3_000064; Spectrum2_001156; Spectrum3_000346; Spectrum4_000283; Spectrum5_000717; Lopac-C-8138; Biomol-NT_000020; Epitope ID:136898; GTPL83; 10H-Phenothiazine-10-propanamine; 2-chloro-N;N-dimethyl-; radical ion(1+); CHLORPROMAZINE [MI]; SCHEMBL8321; CHLORPROMAZINE [INN]; 10-(3-Dimethylaminopropyl)-2-chlorophenothiazine; 2-Chloro-10-(3-dimethylaminopropyl)phenothiazine; Lopac0_000249; Oprea1_110255; BSPBio_000247; BSPBio_002011; CHLORPROMAZINE [HSDB]; KBioGR_000806; KBioGR_002312; KBioSS_000622; KBioSS_002314; MLS003166901; CHLORPROMAZINE [VANDF]; CHLORPROMAZINUM [HPUS]; DivK1c_000624; SPECTRUM1500184; 2-chloro-10-(3-(dimethylamino)propyl)-phenothiazine; SPBio_001111; SPBio_002168; BPBio1_000273; BPBio1_001181; QSPL 401; CHLORPROMAZINE [WHO-DD]; HMS501P06; KBio1_000624; KBio2_000622; KBio2_002312; KBio2_003190; KBio2_004880; KBio2_005758; KBio2_007448; KBio3_001231; KBio3_002792; A10BB02; N05AA01; N05AF03; cMAP_000017; NINDS_000624; Bio1_000457; Bio1_000946; Bio1_001435; HMS1920M03; HMS2089C12; HMS2091E06; HMS3430C19; HMS3886G22; KUC112482N; Pharmakon1600-01500184; BCP03610; CHLORPROMAZINE [ORANGE BOOK]; Tox21_110120; BBL028251; BDBM50001888; CCG-40059; MFCD00133295; NSC756661; NSC756689; s5749; STK182870; AKOS001490972; Tox21_110120_1; 4560 RP; DB00477; KS-5101; NSC-756661; NSC-756689; RP-4560; SDCCGSBI-0050237.P005; IDI1_000624; PS31 - Chlorpromazine/Norchlorpromazine; QTL1_000021; NCGC00015273-01; NCGC00015273-02; NCGC00015273-03; NCGC00015273-04; NCGC00015273-05; NCGC00015273-06; NCGC00015273-07; NCGC00015273-08; NCGC00015273-09; NCGC00015273-10; NCGC00015273-12; NCGC00015273-13; NCGC00015273-14; NCGC00015273-15; NCGC00015273-16; NCGC00015273-17; NCGC00015273-19; NCGC00015273-31; NCGC00024409-04; NCGC00024409-05; NCGC00024409-06; NCGC00024409-07; NCGC00024409-08; KSC-315-032-; SMR001453710; 2-chloro-10-[3-(dimethylamino)propyl]-; SBI-0050237.P004; WLN: T C666 BN ISJ B3N1&1 EG; 2601A; AB00051943; NS00001759; 2601-A; C06906; D00270; AB00051943-15; AB00051943-16; AB00051943_17; AB00051943_18; 3-Chloro-10-(3-dimethylaminopropyl)phenothiazine; L000182; Q407972; SR-01000000012-5; SR-01000000012-6; 2-Chloro-10-(N-dimethylamino-n-propyl)-phenothiazine; BRD-K89997465-001-05-3; 10h-phenothiazine-10-propanamine; 2-chloro-n;n-dimethyl; 1N;1N-dimethyl-3-(2-chloro-10H-10-phenothiazinyl)-1-propanamine; 3-(2-Chloro-10H-phenothiazin-10-yl)-N;N-dimethyl-1-propanamine #; 3-(2-Chloro-10H-phenothiazin-10-yl)-N;N-dimethylpropan1-amine; (chloropromazine) [3-(2-Chloro-phenothiazin-10-yl)-propyl]-dimethyl-amine; (chlorpromazine)[3-(2-Chloro-phenothiazin-10-yl)-propyl]-dimethyl-amine; [3-(2-Chloro-phenothiazin-10-yl)-propyl]-dimethyl-amine (chlor-promazine); [3-(2-Chloro-phenothiazin-10-yl)-propyl]-dimethyl-amine( Chlorpromazine); [3-(2-Chloro-phenothiazin-10-yl)-propyl]-dimethyl-amine(clorpromazine); Chlorpromazine;[3-(2-Chloro-phenothiazin-10-yl)-propyl]-dimethyl-amine]

InChI Key

ZPEIMTDSQAKGNT-UHFFFAOYSA-N

InChI

InChI=1S/C17H19ClN2S/c1-19(2)10-5-11-20-14-6-3-4-7-16(14)21-17-9-8-13(18)12-15(17)20/h3-4,6-9,12H,5,...

IUPAC Name

3-(2-chlorophenothiazin-10-yl)-N,N-dimethylpropan-1-amine

CAS Number

50-53-3

Structure Information

Chemical Structure Visualization

SMILES Notation

2D Molecular Drawing

Carbon (C)

Hydrogen (H)

Oxygen (O)

Nitrogen (N)

Sulfur (S)

SDF

40 42 0 0 0 0 0 0 0 0999 V2000
4.7356 -0.8057 -1.8750 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5996 0.0543 -1.5051 N 0 0 0 0 0 0 0 0 0 0 0 0
4.1052 1.368...

Download SDF File (3423 bytes)

Experimental Data

Activity Data

Target Ion Channel

Two-pore channel subunit TPC2

Uniprot Accession Number

Q8NHX9

Function

Agonist

Species

Homo sapiens (Human)

IC₅₀

N/A (Not available)

EC₅₀

EC₅₀: 60000 nM

K_i

N/A (Not available)

K_d

N/A (Not available)

Inhibition

N/A (Not available)

Experimental Conditions

pH 7.4

Holding Potential

Not specified

Temperature

37 °C

Test Method

Fluorometric Imaging Plate Reader (FLIPR) Membrane Potential Assay

Test Species

HEK293 cell (Homo sapiens embryonic kidney 293 cell)

Binding Information

Binding Site

Not specified

Binding Site Residue

Not specified

Disease Information

Related Disease

Not specified

References

DOI

10.1111/febs.15432

URL

N/A (Not available)

PMID

32167471

Patent

N/A (Not available)

Computed Properties

Heavy Atom Count

Rotatable Bonds

logP

4.8944

Complexity

92.194

TPSA (Å²)

6.48

H-Bond Donors

H-Bond Acceptors

Ring Count

New Search

Molecular Details

Basic Molecular Information

Basic Information

Structure Information

Chemical Structure Visualization

Experimental Data

Activity Data

Experimental Conditions

Binding Information

Disease Information

References

Computed Properties